Mars has sold Diamond Animal Health to Veterinary Pharmaceutical Solutions, a portfolio company of Granite Creek Capital Partners
Diamond Animal Health
Diamond Animal Health is a provider of contract manufacturing, research and development (R&D), regulatory, licensing and product distribution services to pharmaceutical and biologics companies in the animal health space. Headquartered in Des Moines, Iowa, and founded in 1952, Diamond provides a one-stop-shop from proof of concept to commercialization for powders, liquids and tablets for a multitude of animal species.
Diamond was sold to Veterinary Pharmaceutical Solutions (VPS), a portfolio company of Granite Creek Capital Partners. Based in St. Peter, Minnesota, VPS is a licensed animal compounding pharmacy primarily focused on supporting the veterinary community in the swine industry. Diamond will operate as a new division of VPS and the combined organization creates an integrated animal health platform that is uniquely positioned to provide a diverse offering of products, services and capabilities.
Roddy O’Neill and Emily Wildes, Lincoln International Managing Directors who co-led the transaction, commented, “We are grateful and honored for the opportunity to have advised the teams throughout this process and are excited for Diamond’s new partnership with VPS and Granite Creek. Diamond has established itself as a preeminent biologic and pharmaceutical development and manufacturing partner in the animal health industry and we look forward to the continued success of the business as part of the broader VPS platform.”
Meet our Senior Team
View More Transactions
Lincoln International advised Aquiline Capital Partners on the acquisition of Health Prime from GPB Capital Holdings
Lincoln International advised Talisman Capital Partners on the sale of ADVOCATE RCM to Ventra Health, a portfolio company of Varsity Healthcare Partners
Lincoln International advised 7Mind on its sale to Gymondo, a portfolio company of Oakley Capital
Lincoln International advised Olive AI on the sale of substantially all of its assets to Waystar and Humata Health
Lincoln International advised EQT on the acquisition of a controlling stake in Indira IVF from TA Associates and promoter family
Lincoln International advised Scantox Group, a portfolio company of Impilo, on its acquisition of QPS Austria’s Neuropharmacology Division
Lincoln International advised Seven Hills Capital on raising capital for Reliable Medical
Lincoln International advised CNS Cares, a portfolio company of Revelstoke Capital Partners, on completing a leveraged dividend recapitalization
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.